Taurine deficiency after intensive chemotherapy and/or radiation

Authors:

Abstract
Taurine, a nonessential amino acid (AA), is the most abundant free AA in the intracellular space. We measured plasma AA concentrations in 36 patients 7–28 d after intensive chemotherapy and/or radiation. Plasma taurine concentrations were uniformly low in all patients (20.0 ± 6.4 µmol/L, x̄ ± SD). Plasma taurine in 11 healthy volunteer control subjects was 45.0 ± 20.3 µmol/L (P < 0.001). Other AA concentrations, specifically those of precursor AAs methionine and cystine, were normal. We prospectively measured plasma AA concentrations in 12 patients before starting and 6–10 d after completing intensive cytotoxic treatment. Values before treatment were 37.2 ± 11.6, 109.6 ± 30.7, and 18.5 ± 4.8 for taurine, cystine, and methionine, respectively, and were 24.3 ± 6.0, 111.2 ± 23.8, and 24.0 ± 14.5 after treatment. Pretreatment plasma taurine correlated directly with the magnitude of decrease in plasma taurine during cytotoxic treatment (n = 12, r = 0.85, P < 0.01 ). Intensive cytotoxic chemotherapy and/or radiation leads to a reduction in plasma taurine concentrations without any change in its precursor AAs, methionine and cystine. The clinical relevance of plasma taurine depletion will need further study.

This publication has 11 references indexed in Scilit: